Ahmad Abdelkhalek
Ahmad Abdelkhalek has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Alyaa Ahmed Ibrahim
Faculty of Medicine, Alexandria University, Alexandria, Egypt
2 shared publications - Amro Ali
Department of Medicine, Community Regional Medical Center, Fresno, California, USA
2 shared publications - Anika Goel
Kakatiya Medical College Telangana India
2 shared publications Ayesha Samad
2 shared publicationsChinenye Okafor
2 shared publicationsDuaa Mohamed
2 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by Elsevier in American Journal of Medicine Open
- Vol. 16
Utilization of Point-of-Care Ultrasound in Routine Patient Care Among Internal Medicine Resident Physicians in the United States
- 1 May 2026
- Published by Elsevier in American Journal of Medicine Open
- Vol. 16
Open AccessUtilization of Point-of-Care Ultrasound in Routine Patient Care Among Internal Medicine Resident Physicians in the United States
- Open Access
- 26 December 2025
- Published by American Society for Inclusion, Diversity, and Equity in Healthcare in ASIDE Cardiovascular
- Vol. 1 (1) , 1-8
Long-Term Mortality Trends in Atrial Fibrillation and Renal Disease in the United States, 1999–2023: A Retrospective Analysis
Background: The coexistence of atrial fibrillation (AF) and renal disease is a significant contributor to mortality and morbidity. However, comprehensive national mortality trends for AF among older adults with renal disease, including demographic and geographic variations, remain largely unexamined. Methods: We performed a retrospective analysis of U.S. adult deaths (≥65 years) from 1999 to 2023 using the CDC WONDER Multiple Cause of Death database. Deaths were included when atrial fibrillation and kidney disease appeared in any mention field of the death certificate, regardless of the underlying cause of death. We calculated crude and age-adjusted mortality rates (CMR, AAMR) per 100,000 population, and temporal trends were assessed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Results: A total of 372,652 deaths were attributed to both AF and renal disease in older adults. The national AAMR increased more than threefold, from 16.67 in 1999 to 54.45 per 100,000 in 2023 (AAPC: 5.10; p < 0.001). Men had higher absolute mortality, but women experienced a slightly steeper increase in AAMR. Non-Hispanic White individuals had the highest absolute mortality, while all racial/ethnic groups showed significant increases. The South reported the most deaths, the Northeast had the highest AAMR, and non-metropolitan areas consistently showed higher AAMR than metropolitan areas. Most deaths occurred in medical facilities (54.55%). Conclusions: Mortality from AF and renal disease has substantially risen over the past 25 years, with marked disparities by sex, race/ethnicity, geography, and urbanization.
- 26 December 2025
- Published by American Society for Inclusion, Diversity, and Equity in Healthcare in ASIDE Cardiovascular
- Vol. 1 (1) , 1-8
Open AccessLong-Term Mortality Trends in Atrial Fibrillation and Renal Disease in the United States, 1999–2023: A Retrospective Analysis
Background: The coexistence of atrial fibrillation (AF) and renal disease is a significant contributor to mortality and morbidity. However, comprehensive national mortality trends for AF among older adults with renal disease, including demographic and geographic variations, remain largely unexamined. Methods: We performed a retrospective analysis of U.S. adult deaths (≥65 years) from 1999 to 2023 using the CDC WONDER Multiple Cause of Death database. Deaths were included when atrial fibrillation and kidney disease appeared in any mention field of the death certificate, regardless of the underlying cause of death. We calculated crude and age-adjusted mortality rates (CMR, AAMR) per 100,000 population, and temporal trends were assessed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Results: A total of 372,652 deaths were attributed to both AF and renal disease in older adults. The national AAMR increased more than threefold, from 16.67 in 1999 to 54.45 per 100,000 in 2023 (AAPC: 5.10; p < 0.001). Men had higher absolute mortality, but women experienced a slightly steeper increase in AAMR. Non-Hispanic White individuals had the highest absolute mortality, while all racial/ethnic groups showed significant increases. The South reported the most deaths, the Northeast had the highest AAMR, and non-metropolitan areas consistently showed higher AAMR than metropolitan areas. Most deaths occurred in medical facilities (54.55%). Conclusions: Mortality from AF and renal disease has substantially risen over the past 25 years, with marked disparities by sex, race/ethnicity, geography, and urbanization.
- Open Access
- 9 November 2025
- Published by American Society for Inclusion, Diversity, and Equity in Healthcare in ASIDE Internal Medicine
- Vol. 2 (3) , 33-42
Twenty-Five Years of Angina–Related Mortality in Elderly Adults Aged ≥ 65 Years: A Retrospective Cohort Study Using Real-World Data from the USA
Introduction: Angina is one of the ischemic heart diseases (IHD) that contributes to major cardiovascular complications up to death. We aim to assess angina-related mortality among adults aged ≥65 years in the U.S. Methods: Nationwide mortality records were obtained from the CDC-WONDER database from 1999 to 2023 among U.S. adults aged ≥65 with angina. Age-adjusted mortality rates (AAMRs) were calculated per 100,000 population. Joinpoint regression analysis was utilized to evaluate average annual percent changes (AAPCs). Results: From 1999 to 2023, a total of 36,544 deaths occurred among the elderly with angina in the U.S. The overall AAMR per 100,000 decreased from 7.52 in 1999 to 3.73 in 2023 (AAPC of -3.18; 95%CI: -3.79 to -2.75; p < 0.001). The AAMR for men decreased from 8.22 in 1999 to 4.75 in 2023 (AAPC of -2.53%; 95%CI: -3.02 to -2.09), and for women decreased from 6.95 in 1999 to 3.02 in 2023 (AAPC: -3.55%; 95%CI: -4.12 to -3.09). Across racial/ethnic groups, the highest overall rates were observed among NH-White individuals, 3.56. Overall, AAMRs were highest in the West, 4.00. The majority of deaths occurred in medical facilities (40.19%). Between 1999 and 2020, rural areas had a higher overall AAMR of 4.37 compared to urban areas, which had a rate of 3.02. Conclusion: Trends in angina-related mortality declined from 1999 to 2023. Higher mortality rates were observed in men, rural areas, the West region, and among NH White individuals. Our findings indicated that these categories require targeted interventions to reduce mortality.
- 9 November 2025
- Published by American Society for Inclusion, Diversity, and Equity in Healthcare in ASIDE Internal Medicine
- Vol. 2 (3) , 33-42
Open AccessTwenty-Five Years of Angina–Related Mortality in Elderly Adults Aged ≥ 65 Years: A Retrospective Cohort Study Using Real-World Data from the USA
Introduction: Angina is one of the ischemic heart diseases (IHD) that contributes to major cardiovascular complications up to death. We aim to assess angina-related mortality among adults aged ≥65 years in the U.S. Methods: Nationwide mortality records were obtained from the CDC-WONDER database from 1999 to 2023 among U.S. adults aged ≥65 with angina. Age-adjusted mortality rates (AAMRs) were calculated per 100,000 population. Joinpoint regression analysis was utilized to evaluate average annual percent changes (AAPCs). Results: From 1999 to 2023, a total of 36,544 deaths occurred among the elderly with angina in the U.S. The overall AAMR per 100,000 decreased from 7.52 in 1999 to 3.73 in 2023 (AAPC of -3.18; 95%CI: -3.79 to -2.75; p < 0.001). The AAMR for men decreased from 8.22 in 1999 to 4.75 in 2023 (AAPC of -2.53%; 95%CI: -3.02 to -2.09), and for women decreased from 6.95 in 1999 to 3.02 in 2023 (AAPC: -3.55%; 95%CI: -4.12 to -3.09). Across racial/ethnic groups, the highest overall rates were observed among NH-White individuals, 3.56. Overall, AAMRs were highest in the West, 4.00. The majority of deaths occurred in medical facilities (40.19%). Between 1999 and 2020, rural areas had a higher overall AAMR of 4.37 compared to urban areas, which had a rate of 3.02. Conclusion: Trends in angina-related mortality declined from 1999 to 2023. Higher mortality rates were observed in men, rural areas, the West region, and among NH White individuals. Our findings indicated that these categories require targeted interventions to reduce mortality.
- 12 July 2024
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 17 (6) , 1258-1285
Comprehensive Quality Analysis of Conventional and Novel Biomarkers in Diagnosing and Predicting Prognosis of Coronary Artery Disease, Acute Coronary Syndrome, and Heart Failure, a Comprehensive Literature Review
Coronary artery disease (CAD), acute coronary syndrome (ACS), and heart failure (HF) are major global health issues with high morbidity and mortality rates. Biomarkers like cardiac troponins (cTn) and natriuretic peptides (NPs) are crucial tools in cardiology, but numerous new biomarkers have emerged, proving increasingly valuable in CAD/ACS. These biomarkers are classified based on their mechanisms, such as fibrosis, metabolism, inflammation, and congestion. The integration of established and emerging biomarkers into clinical practice is an ongoing process, and recognizing their strengths and limitations is crucial for their accurate interpretation, incorporation into clinical settings, and improved management of CVD patients. We explored established biomarkers like cTn, NPs, and CRP, alongside newer biomarkers such as Apo-A1, IL-17E, IgA, Gal-3, sST2, GDF-15, MPO, H-FABP, Lp-PLA2, and ncRNAs; provided evidence of their utility in CAD/ACS diagnosis and prognosis; and empowered clinicians to confidently integrate these biomarkers into clinical practice based on solid evidence. Graphical Abstract
- 12 July 2024
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 17 (6) , 1258-1285
Comprehensive Quality Analysis of Conventional and Novel Biomarkers in Diagnosing and Predicting Prognosis of Coronary Artery Disease, Acute Coronary Syndrome, and Heart Failure, a Comprehensive Literature Review
Coronary artery disease (CAD), acute coronary syndrome (ACS), and heart failure (HF) are major global health issues with high morbidity and mortality rates. Biomarkers like cardiac troponins (cTn) and natriuretic peptides (NPs) are crucial tools in cardiology, but numerous new biomarkers have emerged, proving increasingly valuable in CAD/ACS. These biomarkers are classified based on their mechanisms, such as fibrosis, metabolism, inflammation, and congestion. The integration of established and emerging biomarkers into clinical practice is an ongoing process, and recognizing their strengths and limitations is crucial for their accurate interpretation, incorporation into clinical settings, and improved management of CVD patients. We explored established biomarkers like cTn, NPs, and CRP, alongside newer biomarkers such as Apo-A1, IL-17E, IgA, Gal-3, sST2, GDF-15, MPO, H-FABP, Lp-PLA2, and ncRNAs; provided evidence of their utility in CAD/ACS diagnosis and prognosis; and empowered clinicians to confidently integrate these biomarkers into clinical practice based on solid evidence. Graphical Abstract